BioNxt Solutions Inc. (OTCMKTS:BNXTF) Stock Short Interest Rises 200.0%

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the target of a significant increase in short interest in October. As of October 30th, there was short interest totaling 3,000 shares, an increase of 200.0% from the October 15th total of 1,000 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average daily volume of 10,902 shares, the days-to-cover ratio is currently 0.3 days.

BioNxt Solutions Price Performance

BNXTF remained flat at $0.15 during trading on Friday. The stock has a market cap of $20.95 million, a price-to-earnings ratio of -3.08 and a beta of 0.85. BioNxt Solutions has a 12 month low of $0.10 and a 12 month high of $0.57. The stock has a fifty day simple moving average of $0.23 and a two-hundred day simple moving average of $0.30.

BioNxt Solutions (OTCMKTS:BNXTF) last released its earnings results on Friday, August 28th. The company reported ($0.01) earnings per share (EPS) for the quarter.

BioNxt Solutions Company Profile

BioNxt Solutions Inc. is a biotechnology company developing drug-delivery technologies and pharmaceutical products. Its work includes sublingual dissolving films and other formulations intended to make medicines easier to administer and potentially improve how they are delivered. The company’s development programs include a sublingual formulation of cladribine, a medicine used to treat multiple sclerosis. BioNxt is also pursuing other drug-delivery and therapeutic projects; its products are in development rather than established as marketed treatments.